Zura Bio (ZURA) Return on Equity [ROE] (2023 - 2026)
Zura Bio (ZURA) reported Return on Equity [ROE] of -41.41% for Q2 2026, up 9.31 percentage points from -50.72% a year earlier and up 5.96 percentage points from the prior quarter.
Powered by 
Analysis
Zura Bio (ZURA) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Zura Bio posted Return on Equity [ROE] of -54.94%, down 4.85 percentage points from FY2024.
- By year, Return on Equity [ROE] came in at -50.09% in FY2024 (+370.27 pp) and -420.36% in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q4 2024.
- Year over year, Return on Equity [ROE] gained in four of the last eight quarters, with an average year-over-year change of +14.64 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2024 (a gain of 95.41 percentage points); the low point was Q4 2025 (a drop of 30.34 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -47.38% (Q1 2026), -64.97% (Q4 2025) and -54.88% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Zura Bio | 178.80 Mn | -549.04 Mn | - | -49.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -49.90% |
| Jun 30, 2026 | -41.41% |
| Mar 31, 2026 | -47.38% |
| Dec 31, 2025 | -64.97% |
| Sep 30, 2025 | -54.88% |
| Jun 30, 2025 | -50.72% |
| Mar 31, 2025 | -43.11% |
| Dec 31, 2024 | -34.63% |
| Sep 30, 2024 | -30.26% |
| Jun 30, 2024 | -31.57% |
| Mar 31, 2024 | -94.82% |
| Dec 31, 2023 | -96.42% |
| Sep 30, 2023 | -102.92% |
| Jun 30, 2023 | -126.97% |
API Access
Zura Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ZURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ZURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ZURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();